Disease Burden in the 95+ Population Has Quintupled Since 1990
A sweeping 33-year global analysis reveals cardiometabolic and neurodegenerative diseases dominate health loss in the fastest-growing age group.
Summary
Researchers analyzed Global Burden of Disease data from 18 countries to characterize causes, risk factors, and health-adjusted life expectancy (HALE) among adults aged 95 and older from 1990 to 2023. The absolute disease burden increased more than fivefold, driven overwhelmingly by non-communicable diseases. Ischemic heart disease led in years of life lost, while Alzheimer's disease and dementias dominated years lived with disability. High blood pressure, elevated blood glucose, and kidney dysfunction were the top modifiable risk factors. Despite increases in HALE, frontier analysis suggests nearly a twofold gap remains between current and achievable healthy longevity, pointing to significant room for targeted interventions.
Detailed Summary
As global populations age into their late 90s and beyond, understanding what drives disease and death in the oldest old becomes increasingly urgent. Longer lives do not automatically mean healthier ones, and identifying actionable risk factors in this age group is critical for public health planning and clinical care.
This study used data from the Global Burden of Disease 2023 study and UN World Population Prospects 2024 to analyze 18 countries with the largest populations aged 95 and older. Researchers quantified disability-adjusted life years (DALYs), years of life lost (YLLs), and years lived with disability (YLDs) from 1990 to 2023 across disease categories and risk factor domains. Temporal trends, clustering patterns, and health-adjusted life expectancy (HALE) trajectories were examined using log-linear regression, k-means clustering, and frontier analysis.
The absolute disease burden in this age group increased more than fivefold over 33 years, with non-communicable diseases accounting for roughly 86% of total DALYs. Ischemic heart disease was the leading cause of YLLs, while Alzheimer's disease and other dementias dominated YLDs. Stroke and chronic kidney disease also ranked prominently. During the COVID-19 pandemic peak (2019–2021), mental health disorders including depression and anxiety surged. Metabolic risk factors — especially high systolic blood pressure and elevated fasting plasma glucose — were the top modifiable drivers. Cluster analysis revealed two national profiles: one centered on acute cardiovascular events and one on chronic multisystem disease.
HALE rose from 1.86 years in 1990 to 2.16 years by 2019 before declining during the pandemic and partially recovering. Frontier analysis found nearly a twofold potential for HALE improvement under current socioeconomic conditions, suggesting major untapped gains remain possible.
These findings underscore that cardiometabolic risk management, dementia prevention, and kidney health should be central to strategies targeting healthy aging in the oldest old. However, the study relies on modeled GBD estimates, which carry inherent uncertainty, particularly for populations where direct data are sparse.
Key Findings
- Absolute disease burden in adults aged 95+ increased more than fivefold from 1990 to 2023.
- Non-communicable diseases account for ~86% of total DALYs; ischemic heart disease leads in mortality.
- Alzheimer's disease and dementias are the top driver of years lived with disability in this age group.
- High systolic blood pressure, elevated fasting glucose, and kidney dysfunction are the leading modifiable risk factors.
- Frontier analysis suggests nearly a twofold potential gain in health-adjusted life expectancy is achievable.
Methodology
The study used GBD 2023 and UN 2024 data across 18 countries, quantifying DALYs, YLLs, and YLDs from 1990 to 2023. Temporal trends were assessed via log-linear regression, cross-country patterns via k-means clustering, and longevity potential via frontier analysis.
Study Limitations
The analysis relies on GBD modeled estimates, which may underrepresent the oldest old due to sparse direct data in many countries. Observational and ecological in nature, the study cannot establish causality between risk factors and outcomes. Cross-national heterogeneity in data quality may influence cluster and trend findings.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.